N-Biaryl substituted diazabicycloalkane derivatives as agonists of the alpha7 and alpha4beta2 nACh Receptor

摘要

The invention relates to biaryl substituted diazabicycloalkanes of formula (I), and more particularly bicycloheteroaryl substituted fused diazabicycloalkane derivatives, compositions comprising such compounds, and such compounds for use for treating or preventing conditions and disorders related to both α7 and α4β2 nAChR activity Formula: (I).